Life Sciences
-
What the ECJ’s landmark ruling on defective products liability means for life sciences manufacturers
This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.
-
Changing UK product liability law: potential effects on the healthcare sector
Proactive steps companies in the healthcare sector (or those that insure or invest in those businesses) should take now.
-
UK Supreme Court delivers landmark ruling on AI patentability
The decision has significant implications for the patentability of computer-implemented inventions in UK sectors especially healthcare and life sciences.
-
PMCPA rules AstraZeneca UK responsible for employee’s social media activity
An employee clicking “like” on a third-party LinkedIn post was found to be a breach of seven clauses of the ABPI Code.
-
Amid calls of political favoritism, FDA continues to award national priority drug vouchers
In addition to questions from members of Congress, the program is facing scrutiny from medical organizations over whether it’s putting politics before science.